IRIS Accounts Production v24.2.0.383 05832230 director 6.4.23 5.4.24 5.4.24 false true false false false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh058322302023-04-05058322302024-04-05058322302023-04-062024-04-05058322302022-04-05058322302022-04-062023-04-05058322302023-04-0505832230ns15:EnglandWales2023-04-062024-04-0505832230ns14:PoundSterling2023-04-062024-04-0505832230ns10:Director12023-04-062024-04-0505832230ns10:PrivateLimitedCompanyLtd2023-04-062024-04-0505832230ns10:Micro-entities2023-04-062024-04-0505832230ns10:AuditExempt-NoAccountantsReport2023-04-062024-04-0505832230ns10:FullAccounts2023-04-062024-04-0505832230ns10:RegisteredOffice2023-04-062024-04-0505832230ns5:CurrentFinancialInstruments2024-04-0505832230ns5:CurrentFinancialInstruments2023-04-05
REGISTERED NUMBER: 05832230 (England and Wales)















Unaudited Financial Statements for the Year Ended 5 April 2024

for

McDonough Clinical Research Limited

McDonough Clinical Research Limited (by shares) (Registered number: 05832230)






Contents of the Financial Statements
for the Year Ended 5 April 2024




Page

Company Information 1

Balance Sheet 2


McDonough Clinical Research Limited (by shares)

Company Information
for the Year Ended 5 April 2024







DIRECTOR: Ms Brenna Anne Mcdonough





REGISTERED OFFICE: 67 Westow Street
Upper Norwood
London
England
SE19 3RW





REGISTERED NUMBER: 05832230 (England and Wales)





ACCOUNTANTS: CWF & Partners (TWB Accountants) Ltd
67 Westow Street
Upper Norwood
London
SE19 3RW

McDonough Clinical Research Limited (by shares) (Registered number: 05832230)

Balance Sheet
5 April 2024

5.4.24 5.4.23
£    £    £    £   
FIXED ASSETS 1,137 100,547

CURRENT ASSETS 206,632 133,582

CREDITORS
Amounts falling due within one year (8,868 ) (16,236 )
NET CURRENT ASSETS 197,764 117,346
TOTAL ASSETS LESS CURRENT
LIABILITIES

198,901

217,893

CAPITAL AND RESERVES 198,901 217,893

NOTE TO THE FINANCIAL STATEMENTS

1. AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was 1 (2023 - 1 ) .



The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 5 April 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 5 April 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the director and authorised for issue on 10 September 2024 and were signed by:





Ms Brenna Anne Mcdonough - Director